COVID-19 continues to dominate the news. As I write this blog the United States is reporting 793,919 confirmed cases and 42,474 deaths – the numbers change daily. Lots of data is emerging from China, Italy, and the hardest hit places in the United States such as New York City. While this is a … Read More
Author Archives: Mary McGowan MD
As the days go by we are learning more about the cardiac complications related to infection with COVID-19. One concern that has emerged is the potential increased cardiac risk for people with elevated Lipoprotein(a) levels, or Lp(a) for short. As you likely know, people with familial hypercholesterolemia … Read More
As coronavirus virus disease 2019 (COVID-19) continues to spread in the United States and worldwide, the FH Foundation has received several questions related to the risk posed by COVID 19 for people with familial hypercholesterolemia (FH) and potential concerns about FH treatments at this time.
People … Read More
We find ourselves in one of the most challenging situations in world history. It is crucial for all of us to follow the guidance on handling the coronavirus (COVID-19) provided by the CDC, which is updated daily. This said, it is important for our FH community to be aware of … Read More
You may have heard about Lipoprotein (a), Lp(a) or often referred to as “Lp little a.” Lp(a) is an independent risk factor for cardiovascular disease.The level of Lp(a) found in a person’s blood is entirely genetically predetermined. This means that unlike other cardiac risk factors, Lp(a) can’t … Read More